Latanoprost Patent Expiration
Latanoprost is Used for managing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It was first introduced by Upjohn Us 2 Llc
Latanoprost Patents
Given below is the list of patents protecting Latanoprost, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Iyuzeh | US8637054 | Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives | Jul 08, 2031 | Thea Pharma |
| Xelpros | US9629852 | Ophthalmic composition comprising a prostaglandin | Sep 12, 2029 | Sun Pharm |
| Xelpros | US9539262 | Ophthalmic composition comprising a prostaglandin | Oct 15, 2028 | Sun Pharm |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Latanoprost's patents.
Latest Legal Activities on Latanoprost's Patents
Given below is the list recent legal activities going on the following patents of Latanoprost.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Jul, 2024 | US9539262 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Oct, 2020 | US9629852 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Jul, 2020 | US9539262 |
| Recordation of Patent Grant Mailed Critical | 25 Apr, 2017 | US9629852 |
| Patent Issue Date Used in PTA Calculation Critical | 25 Apr, 2017 | US9629852 |
| Email Notification Critical | 06 Apr, 2017 | US9629852 |
| Issue Notification Mailed Critical | 05 Apr, 2017 | US9629852 |
| Dispatch to FDC | 17 Mar, 2017 | US9629852 |
| Application Is Considered Ready for Issue Critical | 16 Mar, 2017 | US9629852 |
| Issue Fee Payment Verified Critical | 13 Mar, 2017 | US9629852 |
Latanoprost's Family Patents
Explore Our Curated Drug Screens
Latanoprost Generic API Manufacturers
Several generic applications have been filed for Latanoprost. The first generic version for Latanoprost was by Apotex Inc and was approved on Mar 22, 2011. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Sep 3, 2019.
Given below is the list of companies who have filed for Latanoprost generic, along with the locations of their manufacturing plants worldwide.
1. AMRING PHARMS
Amring Pharmaceuticals Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Amring Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Mar 22, 2011 |
2. APOTEX INC
Apotex Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Discontinued | OPHTHALMIC | N/A | Mar 22, 2011 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
3. BAUSCH AND LOMB
Bausch And Lomb Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Bausch And Lomb.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Mar 22, 2011 |
Manufacturing Plant Locations New
Bausch And Lomb's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bausch And Lomb as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
4. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Discontinued | OPHTHALMIC | N/A | Jul 19, 2011 |
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Discontinued | OPHTHALMIC | N/A | Sep 3, 2019 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
6. FDC LTD
Fdc Ltd has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Fdc Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Apr 22, 2016 |
7. RYAN LABS
Ryan Laboratories Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Ryan Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Feb 11, 2013 |
8. SANDOZ
Sandoz Inc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Mar 22, 2011 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
9. SOMERSET
Somerset Therapeutics Llc has filed for 1 generic for Latanoprost. Given below are the details of the strengths of this generic introduced by Somerset.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.005% | solution/drops | Prescription | OPHTHALMIC | AT | Mar 22, 2011 |
Manufacturing Plant Locations New
Somerset's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Somerset as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||